Sherman Matthew L - Insider Non-Derivative Transactions at Deciphera Pharmaceuticals, Inc. (NA) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jun 11, 2024, Sherman Matthew L's relationship to Deciphera Pharmaceuticals, Inc. (NA) is Officer (EVP & Chief Medical Officer), and currently has 144,290 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other NA insiders.
Data Source: SEC.
Sherman Matthew L - Insider Non-Derivative Transactions at NA
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jun 12, 2024 | U -- (Common Stock) | 72261 | 0 | 0 |
| Jun 12, 2024 | Disposition -- (Common Stock) | 72029 | 0 | 72261 |
| Jun 12, 2024 | Acquisition -- (Common Stock) | 34157 | 0 | 144290 |